Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest. 2005;115(12):3318–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leboime A, et al. Osteoporosis and mortality. Joint Bone Spine. 2010;77(Suppl 2):S107–12.

Article  PubMed  Google Scholar 

Wade SW, et al. Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos. 2014;9:182.

Article  CAS  PubMed  Google Scholar 

Singer A, et al. Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc. 2015;90(1):53–62.

Article  PubMed  Google Scholar 

Camacho PM, et al. American association of clinical endocrinologists and american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016. Endocr Pract. 2016;22(Suppl 4):1–42.

Article  PubMed  Google Scholar 

Bonjour J-P, et al. The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex. 2009;51:s5–17.

Article  PubMed  Google Scholar 

Suresh E, Pazianas M, Abrahamsen B. Safety issues with bisphosphonate therapy for osteoporosis. Rheumatology (Oxford). 2014;53(1):19–31.

Article  CAS  PubMed  Google Scholar 

Qaseem A, et al. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med. 2017;166(11):818–39.

Article  PubMed  Google Scholar 

Shadmand M, et al. Bringing attention to lesser-known bone remodeling pathways. Clin Rev Bone Miner Metab. 2018;16(3):95–102.

Article  CAS  Google Scholar 

Bergsma A, et al. Regulation of cytoskeleton and adhesion signaling in osteoclasts by tetraspanin CD82. Bone Rep. 2019;10:100196.

Article  PubMed  PubMed Central  Google Scholar 

Bergsma A, et al. Global deletion of tetraspanin CD82 attenuates bone growth and enhances bone marrow adipogenesis. Bone. 2018;113:105–13.

Article  CAS  PubMed  Google Scholar 

Han L, et al. Loss of chemerin triggers bone remodeling in vivo and in vitro. Mol Metab. 2021;53:101322.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tariq S, et al. Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females. Front Endocrinol (Lausanne). 2022;13:1024860.

Article  PubMed  Google Scholar 

Muruganandan S, et al. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells. 2013;31(10):2172–82.

Article  CAS  PubMed  Google Scholar 

Erratum: Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women: Erratum. Medicine (Baltimore), 2016;95(43):e561e.

Tariq S, Tariq S, Shahzad M. Association of serum chemerin with calcium, alkaline phosphatase and bone mineral density in postmenopausal females. Pak J Med Sci. 2021;37(2):384–8.

Article  PubMed  PubMed Central  Google Scholar 

Jiang XY, et al. Association of high serum chemerin with bone mineral density loss and osteoporotic fracture in elderly Chinese women. Int J Womens Health. 2022;14:107–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Terzoudis S, et al. Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2016;28(7):814–9.

Article  CAS  PubMed  Google Scholar 

He J, et al. Serum chemerin levels in relation to osteoporosis and bone mineral density: a case-control study. Dis Markers. 2015;2015:786708.

Article  PubMed  PubMed Central  Google Scholar 

Shi L, et al. Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women. Medicine (Baltimore). 2016;95(35):e4583.

Article  CAS  PubMed  Google Scholar 

Menzel J, et al. The cross-sectional association between chemerin and bone health in peri/pre and postmenopausal women: results from the EPIC-Potsdam study. Menopause. 2018;25(5):574–8.

Article  PubMed  PubMed Central  Google Scholar 

Tariq S, et al. Effect of ibandronate therapy on serum chemerin, vaspin, omentin-1 and osteoprotegerin (OPG) in postmenopausal osteoporotic females. Front Pharmacol. 2022;13: 822671.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Min W, et al. The decline of whole-body glucose metabolism in ovariectomized rats. Exp Gerontol. 2018;113:106–12.

Article  CAS  PubMed  Google Scholar 

Li J, et al. Chemerin located in bone marrow promotes osteogenic differentiation and bone formation via Akt/Gsk3beta/beta-catenin axis in mice. J Cell Physiol. 2021;236(8):6042–54.

Article  CAS  PubMed  Google Scholar 

Guo Y, et al. Simvastatin inhibits the adipogenesis of bone marrow-derived mesenchymal stem cells through the downregulation of chemerin/CMKLR1 signaling. Int J Mol Med. 2020;46(2):751–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao F, et al. Chemerin/ChemR23 signaling mediates the effects of ultra-high molecular weight polyethylene wear particles on the balance between osteoblast and osteoclast differentiation. Ann Transl Med. 2021;9(14):1149.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao H, et al. Chemokine-like receptor 1 deficiency leads to lower bone mass in male mice. Cell Mol Life Sci. 2019;76(2):355–67.

Article  CAS  PubMed  Google Scholar 

Tanaka KI, et al. FAM210A is a novel determinant of bone and muscle structure and strength. Proc Natl Acad Sci U S A. 2018;115(16):E3759–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abi-Rafeh J, et al. Genetic deletion of menin in mouse mesenchymal stem cells: an experimental and computational analysis. JBMR Plus. 2022;6(5):e10622.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Troka I, et al. Effect of menin deletion in early osteoblast lineage on the mineralization of an in vitro 3D osteoid-like dense collagen gel matrix. Biomimetics. 2022. https://doi.org/10.3390/biomimetics7030101.

Article  PubMed  PubMed Central  Google Scholar 

Kanazawa I, et al. Osteoblast menin regulates bone mass in vivo. J Biol Chem. 2015;290(7):3910–24.

Article  CAS  PubMed  Google Scholar 

Liu P, et al. Loss of menin in osteoblast lineage affects osteocyte-osteoclast crosstalk causing osteoporosis. Cell Death Differ. 2017;24(4):672–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sowa H, et al. Inactivation of menin, the product of the multiple endocrine neoplasia type 1 gene, inhibits the commitment of multipotential mesenchymal stem cells into the osteoblast lineage. J Biol Chem. 2003;278(23):21058–69.